1. Home
  2. RGTI vs RYTM Comparison

RGTI vs RYTM Comparison

Compare RGTI & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rigetti Computing Inc.

RGTI

Rigetti Computing Inc.

HOLD

Current Price

$17.22

Market Cap

7.8B

Sector

Technology

ML Signal

HOLD

Logo Rhythm Pharmaceuticals Inc.

RYTM

Rhythm Pharmaceuticals Inc.

HOLD

Current Price

$89.85

Market Cap

6.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGTI
RYTM
Founded
2013
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.8B
6.4B
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
RGTI
RYTM
Price
$17.22
$89.85
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
14
Target Price
$33.50
$129.43
AVG Volume (30 Days)
22.3M
712.7K
Earning Date
01-01-0001
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
28.34
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$58.38
Revenue Next Year
$179.00
$83.95
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.86
$45.91
52 Week High
$58.15
$122.20

Technical Indicators

Market Signals
Indicator
RGTI
RYTM
Relative Strength Index (RSI) 44.93 35.17
Support Level $14.17 $83.98
Resistance Level $17.42 $96.92
Average True Range (ATR) 1.21 5.65
MACD 0.44 -0.86
Stochastic Oscillator 57.11 15.42

Price Performance

Historical Comparison
RGTI
RYTM

About RGTI Rigetti Computing Inc.

Rigetti Computing Inc is engaged in the business of full-stack quantum computing. The company offers full-stack quantum computing platform as a cloud service to a wide range of end-users, directly through its Rigetti QCS platform, and also through cloud service providers. Its proprietary quantum-classical infrastructure provides ultra-low latency integration with public and private clouds for high-performance practical quantum computing. The company has developed the industry's first multi-chip quantum processor for scalable quantum computing systems. Geographically, the company derives the majority of its revenue from the United States.

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

Share on Social Networks: